Myeloid cell heterogeneity in the tumor microenvironment and therapeutic implications for childhood central nervous system (CNS) tumors
- 5 December 2022
- journal article
- review article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 374, 578009
Abstract
No abstract availableKeywords
This publication has 141 references indexed in Scilit:
- Protumor Activities of the Immune Response: Insights in the Mechanisms of Immunological Shift, Oncotraining, and OncopromotionJournal of Oncology, 2013
- CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasisNature, 2011
- Alternative Activation of Macrophages: Mechanism and FunctionsImmunity, 2010
- Macrophage Diversity Enhances Tumor Progression and MetastasisCell, 2010
- Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TANCancer Cell, 2009
- Myeloid-derived suppressor cells as regulators of the immune systemNature Reviews Immunology, 2009
- Malignant Astrocytomas Originate from Neural Stem/Progenitor Cells in a Somatic Tumor Suppressor Mouse ModelCancer Cell, 2009
- Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancerNature Medicine, 2007
- Intratumoral cytokines/chemokines/growth factors and tumor infiltrating dendritic cells: friends or enemies?Cancer and Metastasis Reviews, 2006
- Regulation of immune responses by L-arginine metabolismNature Reviews Immunology, 2005